Business Description
AlphaHelix Molecular Diagnostics AB
NAICS : 334517
SIC : 3844
ISIN : SE0000885501
Compare
Compare
Traded in other countries / regions
ALPH.Sweden4MB.Germany IPO Date
2006-09-15Description
AlphaHelix Molecular Diagnostics AB develops, manufactures, and markets products for DNA-identification and quantitation in molecular diagnostics and life science research. Its product inlcude Rob, BugScreener MRSA, and aAmp. The company applications inlcude Diagnostics, PCR and Liquid handling.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.09 | |||||
| Equity-to-Asset | 0.51 | |||||
| Debt-to-Equity | 0.14 | |||||
| Debt-to-EBITDA | -0.12 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 0.57 | |||||
| Beneish M-Score | -5.29 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -2.5 | |||||
| 3-Year Book Growth Rate | 42.2 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36.08 | |||||
| 9-Day RSI | 38.89 | |||||
| 14-Day RSI | 41.82 | |||||
| 6-1 Month Momentum % | -53.44 | |||||
| 12-1 Month Momentum % | -53 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.46 | |||||
| Quick Ratio | 0.94 | |||||
| Cash Ratio | 0.48 | |||||
| Days Inventory | 150.77 | |||||
| Days Sales Outstanding | 60.81 | |||||
| Days Payable | 50.52 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.3 | |||||
| Shareholder Yield % | -3.08 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 47.76 | |||||
| Operating Margin % | -46.67 | |||||
| Net Margin % | -49.04 | |||||
| FCF Margin % | -19.65 | |||||
| ROE % | -82.01 | |||||
| ROA % | -53.88 | |||||
| ROIC % | -66.83 | |||||
| ROC (Joel Greenblatt) % | -327.16 | |||||
| ROCE % | -79.36 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.71 | |||||
| PB Ratio | 2.06 | |||||
| Price-to-Tangible-Book | 5.2 | |||||
| EV-to-EBIT | -1.21 | |||||
| EV-to-EBITDA | -1.49 | |||||
| EV-to-Revenue | 0.6 | |||||
| EV-to-FCF | -3.06 | |||||
| Price-to-Projected-FCF | 13 | |||||
| Price-to-Median-PS-Value | 0.24 | |||||
| Price-to-Net-Current-Asset-Value | 6.5 | |||||
| Earnings Yield (Greenblatt) % | -82.64 | |||||
| FCF Yield % | -27.65 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
AlphaHelix Molecular Diagnostics AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 23.199 | ||
| EPS (TTM) (kr) | -0.187 | ||
| Beta | -0.06 | ||
| Volatility % | 41.05 | ||
| 14-Day RSI | 41.82 | ||
| 14-Day ATR (kr) | 0.042501 | ||
| 20-Day SMA (kr) | 0.3046 | ||
| 12-1 Month Momentum % | -53 | ||
| 52-Week Range (kr) | 0.12 - 0.79 | ||
| Shares Outstanding (Mil) | 63.4 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
AlphaHelix Molecular Diagnostics AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
AlphaHelix Molecular Diagnostics AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
AlphaHelix Molecular Diagnostics AB Frequently Asked Questions
What is AlphaHelix Molecular Diagnostics AB(XSAT:ALPH)'s stock price today?
The current price of XSAT:ALPH is kr0.26. The 52 week high of XSAT:ALPH is kr0.79 and 52 week low is kr0.12.
When is next earnings date of AlphaHelix Molecular Diagnostics AB(XSAT:ALPH)?
The next earnings date of AlphaHelix Molecular Diagnostics AB(XSAT:ALPH) is 2024-08-22.
Does AlphaHelix Molecular Diagnostics AB(XSAT:ALPH) pay dividends? If so, how much?
AlphaHelix Molecular Diagnostics AB(XSAT:ALPH) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers